...
首页> 外文期刊>Medicine. >Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas > 5 cm Without Extrahepatic Metastases An Imaging-Based Retrospective Study
【24h】

Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas > 5 cm Without Extrahepatic Metastases An Imaging-Based Retrospective Study

机译:单侧肝癌> 5 cm无肝外转移的肝切除术与经导管动脉化疗栓塞之间的电晕增强和镶嵌结构之间的关系,基于影像学的回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Corona enhancement and mosaic architecture are 2 radiologic features of hepatocellular carcinoma (HCC). However, neither their prognostic values nor their impacts on the selection of liver resection (LR) versus transcatheter arterial chemoembolization (TACE) as treatment modalities have been established. We retrospectively analyzed 275 patients with a single HCC lesion >5 cm without extrahepatic metastasis treated with LR or TACE. In LR patients, the overall survival (OS) and time to progression (TTP) were compared between corona enhancement negative (corona-) versus positive (corona+) and mosaic architecture negative (mosaic-) versus positive (mosaic+) patients. Furthermore, by the combination of corona and mosaic, LR patients were divided into negative for both corona and mosaic patterns (LR-/-), positive for only 1 feature (LR+/-), and positive for both (LR+/+); their OS and TTP were compared to those of the TACE group. Cox regression was performed to identify independent factors for OS. In the survival plots for LR, corona- had better OS and TTP than corona+, and mosaic- had better OS than mosaic+. There was no significant difference in TTP between the subgroups. On Cox regression analysis, corona enhancement, but not mosaic architecture, was a significant factor for OS, whereas neither were a significant factor for TTP. In TACE patients, neither corona nor mosaic patterns had significant correlations with OS or TTP. In the whole population, LR-/ and LR+/- subgroups had similar OS, which was better than the LR+/+ and TACE groups. Moreover, LR-/- and LR+/- patients had better TTP than TACE patients, but there were no differences between the LR-/- versus LR+/-, LR-/ versus LR+/+, LR+/- versus LR+/+, and LR+/+ versus TACE groups. On Cox regression analysis, the presence of corona/mosaic patterns was an independent prognostic factor for OS. Our results showed that, for patients with a single HCC >5 cm without extrahepatic metastasis, corona and mosaic patterns are indicators of limited LR efficacy. When both of the features are present, TACE can be used instead of LR with no negative influence on survival.
机译:电晕增强和镶嵌结构是肝细胞癌(HCC)的2个放射学特征。然而,既未确定其预后价值,也未确定其对肝切除术(LR)与经导管动脉化疗栓塞(TACE)的选择作为治疗方式。我们回顾性分析了275例单发HCC病变> 5 cm且未进行LR或TACE治疗的肝外转移的患者。在LR患者中,比较了电晕增强阴性(corona-)与阳性(corona +)和镶嵌结构阴性(mosaic-)与阳性(mosaic +)患者的总生存期(OS)和进展时间(TTP)。此外,通过电晕和镶嵌的组合,将LR患者分为电晕和镶嵌图案均为阴性(LR-/-),仅1个特征为阳性(LR +/-)和均为正(LR + / +)。他们的操作系统和TTP与TACE组进行了比较。进行Cox回归以确定OS的独立因素。在LR的生存曲线中,电晕-的OS和TTP比电晕+更好,而镶嵌-的OS优于镶嵌+。亚组之间的TTP没有显着差异。在Cox回归分析中,电晕增强而不是镶嵌结构是OS的重要因素,而两者都不是TTP的重要因素。在TACE患者中,电晕或镶嵌模式均与OS或TTP无显着相关性。在整个人群中,LR- /和LR +/-亚组的OS相似,这比LR + / +和TACE组更好。此外,LR-/-和LR +/-患者的TTP优于TACE患者,但LR-/-与LR +/-,LR- /与LR + / +,LR +/-与LR + / +之间没有差异,以及LR + / +与TACE组。在Cox回归分析中,电晕/马赛克图案的存在是OS的独立预后因素。我们的结果表明,对于单个HCC> 5 cm且无肝外转移的患者,电晕和镶嵌模式是LR疗效有限的指标。当同时具有这两种功能时,可以使用TACE代替LR,而对存活率没有负面影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号